Albuterol Delivery via Facial and Tracheostomy Route in a Model of a Spontaneously Breathing Child

References

1. 1.↵
   1. Sherman JM,
   2. Davis S,
   3. Albamonte-Petrick S,
   4. Chatburn RL,
   5. Fitton C,
   6. Green C,
   7. et al

   . Care of the child with a chronic tracheostomy. Am J Respir Crit Care Med 2000;161(1):297–308.

   OpenUrlPubMedWeb of Science
2. 2.↵
   1. Amirav I,
   2. Newhouse MT

   . Aerosol therapy in tracheotomized children: time for guidelines! Respir Care 2012;57(8):1350.

   OpenUrlFREE Full Text
3. 3.↵
   1. Pitance L,
   2. Reychler G,
   3. Vecellio L,
   4. Leal T,
   5. Reychler H,
   6. Liistro G

   . Influence of tracheostomy on lung deposition in spontaneously breathing patient. Pitance L, PhD thesis, Catholic University of Louvain, 2013;117–132.
4. 4.↵
   1. Piccuito CM,
   2. Hess DR

   . Albuterol delivery via tracheostomy tube. Respir Care 2005;50(8):1071–1076.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Ari A,
   2. Harwood RJ,
   3. Sheard MM,
   4. Fink JB

   . An in-vitro evaluation of aerosol delivery through tracheostomy and endotracheal tubes using different interfaces. Respir Care 2012;57(7):1066–1070.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Berlinski A,
   2. Chavez A

   . Albuterol delivery via metered dose inhaler in a spontaneously breathing pediatric tracheostomy model. Pediatr Pulmonol 2013;48(10):1026–1034.

   OpenUrlPubMed
7. 7.↵
   1. Berlinski A

   . Nebulized allbuterol delivery in a model of spontaneously breathing children with tracheostomy. Respir Care 2013;58(12):2076–2086.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Pitance L,
   2. Vecellio L,
   3. Delval G,
   4. Reychler G,
   5. Reychler H,
   6. Liistro G

   . Aerosol delivery through tracheostomy tubes: an in vitro study. J Aerosol Med Pulm Drug Deliv 2013;26(2):76–83.

   OpenUrlPubMed
9. 9.↵
   1. Alhamad B

   . The effect of aerosol devices and administration techniques on drug delivery in a simulated spontaneously breathing pediatric model with a tracheostomy. MS thesis, Georgia State University, Atlanta, GA, 2013.
10. 10.↵
    1. Willis LD,
    2. Berlinski A

    . Survey of aerosol delivery techniques to spontaneously breathing tracheostomized children. Respir Care 2012;57(8):1234–1241.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Berlinski A,
    2. Xi J

    . Characterization of nebulized aerosols using a next generation impactor and an anatomically correct pediatric airway model. Respir Drug Deliv 2014;3:637–640.

    OpenUrl
12. 12.↵
    1. Chavez A,
    2. McCracken A,
    3. Berlinski A

    . Effect of face mask static dead volume, respiratory rate and tidal volume on inhaled albuterol delivery. Pediatr Pulmonol 2010;45(3):224–229.

    OpenUrlPubMed
13. 13.↵
    1. Marple VA,
    2. Olson BA,
    3. Santhanakrishnan K,
    4. Mitchell JP,
    5. Murray SC,
    6. Hudson-Curtis BL

    . Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: Archival calibration. J Aerosol Med 2003;16(3):301–324.

    OpenUrlPubMed
14. 14.↵
    1. Berlinski A

    . Effect of mask dead space and occlusion of mask holes on delivery of nebulized albuterol. Respir Care 2014;59(8):1228–1232.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Ahrens RC,
    2. Ries RA,
    3. Popendorf W,
    4. Wiese JA

    . The delivery of theraputic aerosols through endotracheal tubes. Pediatr Pulmonol 1986;2(1):19–26.

    OpenUrlPubMedWeb of Science
16. 16.↵
    1. Hautmann J,
    2. Godoy SE,
    3. Marshik P,
    4. Chand R,
    5. McConville J,
    6. Krishna S,
    7. et al

    . Effect of time between actuation on the dose variability for three metered dose inhalers. Respir Drug Deliv Eur 2013;2:429–434.

    OpenUrl
17. 17.↵
    EPR-3. Expert Panel Report 3: guidelines for the diagnosis and management of asthma (EPR−3 2007). NIH Publication No. 08-5846. Bethesda, MD: National Institutes of Health; NHLBI; National Asthma Education and Prevention Program: 2008.